Bull
$27.38
Precio del escenario
$29.670
+0.632 (+2.13%)Al cierre
HealthStream, Inc. provides platform-delivered workforce solutions. Its solutions include Software-as-a-Service (SaaS), subscription-based applications used by healthcare organizations to meet a range of their workforce development needs around learning, clinical development, credentialing, and scheduling. Its content libraries allow customers to subscribe to an array of courseware, which includes content from healthcare and nursing associations, medical and healthcare publishers, and other content providers. Its scheduling solutions provide customers with real-time visibility into clinical staff scheduling. Its credentialing, privileging, and enrollment solution, CredentialStream, provides customers a user experience with a continual stream of enhancements, evidence-based content, and curated data, which provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure, and other credentials.
HealthStream Inc is currently trading at $29.38, which is above the analyst price target of $27, indicating that it may be overvalued at this time. The stock has an RSI of 69.19, suggesting it is nearing overbought territory. Although the company reported a solid Q2 with a 12.5% revenue increase to $83.73 million and earnings per share of $0.23, the forward P/E ratio of 45.66 is significantly high, indicating potential overvaluation. Furthermore, insider selling has increased by 146.37%, which raises concerns about the stock's future performance. Therefore, while the company shows growth potential, it may be prudent to hold rather than buy at the current price.
Canaccord
$27
2026-07-21
Canaccord
2026-07-21
Precio objetivo
$27
Canaccord
$24
2026-05-06
Canaccord
2026-05-06
Precio objetivo
$24
Canaccord
$21
2026-02-25
Canaccord
2026-02-25
Precio objetivo
$21
Canaccord
$25
2026-01-08
Canaccord
2026-01-08
Precio objetivo
$25
Canaccord
$28
2025-08-07
Canaccord
2025-08-07
Precio objetivo
$28
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

HealthStream Reports Record Q2 2026 Earnings and Adjusted EBITDA

HealthStream Declares Quarterly Dividend of $0.035 per Share

HealthStream Reports Q2 Earnings Growth

HealthStream Q2 Earnings Exceed Expectations

HealthStream Cyberattack: No Major Impact on Financials
HealthStream, Inc. provides platform-delivered workforce solutions. Its solutions include Software-as-a-Service (SaaS), subscription-based applications used by healthcare organizations to meet a range of their workforce development needs around learning, clinical development, credentialing, and scheduling. Its content libraries allow customers to subscribe to an array of courseware, which includes content from healthcare and nursing associations, medical and healthcare publishers, and other content providers. Its scheduling solutions provide customers with real-time visibility into clinical staff scheduling. Its credentialing, privileging, and enrollment solution, CredentialStream, provides customers a user experience with a continual stream of enhancements, evidence-based content, and curated data, which provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure, and other credentials. It operates in the Technology sector (SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ET industry).
HealthStream Inc is currently trading at $29.38, which is above the analyst price target of $27, indicating that it may be overvalued at this time. The stock has an RSI of 69.19, suggesting it is nearing overbought territory. Although the company reported a solid Q2 with a 12.5% revenue increase to $83.73 million and earnings per share of $0.23, the forward P/E ratio of 45.66 is significantly high, indicating potential overvaluation. Furthermore, insider selling has increased by 146.37%, which raises concerns about the stock's future performance. Therefore, while the company shows growth potential, it may be prudent to hold rather than buy at the current price.
9 analysts cover HSTM: 4 rate it Buy, 5 Hold and 0 Sell. The average price target is 25.00.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.